1 not yet recruiting, 1 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
Follow Jaw Neoplasms: new trials by email Literature Review of Jaw Neoplasms trials Research Report on Jaw Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) Hypofractionated Stereotactic Body Radiotherapy (SBRT), Pembrolizumab, Ficerafusp alfa - Head and Neck Squamous Cell Carcinoma, HPV-Negative Squamous Cell Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Washington University School of Medicine | 45 | 2026-11-30 | 2026-11-03 |
| Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction EB-CMF - Mandible Tumor, Mandibular Injuries | Phase 1 / Phase 2 | Unknown | Epibone, Inc. | 6 | 2021-03-31 | 2022-05-27 |
Carcinoma, Squamous Cell (1) · Congenital Abnormalities (1) · Head and Neck Neoplasms (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1) · Lip Neoplasms (1) · Mandibular Injuries (1) · Mandibular Neoplasms (1) · Mouth Neoplasms (1) · Oropharyngeal Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Tongue Neoplasms (1)
Bone Diseases (2) · Bone Neoplasms (2) · Jaw Diseases (2) · Musculoskeletal Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Skull Neoplasms (2) · Stomatognathic Diseases (2) · Carcinoma (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Craniocerebral Trauma (1) · Facial Injuries (1) · Laryngeal Diseases (1) · Lip Diseases (1)
pembrolizumab (1)
Epibone, Inc. (1) · Washington University School of Medicine (1)
United States (2)
Brian R Gastman, MD (1) · Sana Karam, MD, PhD (1) · Sidharth Puram, MD, PhD (1)